Abstract
Background Prostate cancer (PC) is the most common cancer among men. Implementation of prostate-specific antigen (PSA) screening in Western countries has led to increase of incidence, but not mortality from PC. PSA screening in Arkhangelsk region, Northwest Russia was introduced only in 2006. We assessed its impact on survival in PC patients using the data from the regional cancer registry. Methods Data on all cases …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
